Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China
· Delayed Price · Currency is CNY 29.43
-0.09 (-0.30%)
Mar 9, 2026, 4:00 PM EDT
SHE:301263 Revenue
Guangdong Taienkang Pharmaceutical had revenue of 178.75M CNY in the quarter ending September 30, 2025, with 1.02% growth. This brings the company's revenue in the last twelve months to 674.49M, down -10.31% year-over-year. In the year 2024, Guangdong Taienkang Pharmaceutical had annual revenue of 721.03M, down -5.23%.
Revenue (ttm)
674.49M
Revenue Growth
-10.31%
P/S Ratio
18.48
Revenue / Employee
623.95K
Employees
1,081
Market Cap
12.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 721.03M | -39.76M | -5.23% |
| Jan 1, 2024 | 760.79M | -22.69M | -2.90% |
| Jan 1, 2023 | 783.48M | 129.83M | 19.86% |
| Jan 1, 2022 | 653.65M | -55.33M | -7.80% |
| Dec 31, 2020 | 708.98M | 212.59M | 42.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Shanghai Haoyuan Chemexpress | 2.87B |
| Shenzhen Chipscreen Biosciences | 909.54M |
| Beijing Aosaikang Pharmaceutical | 1.83B |
| Porton Pharma Solutions | 3.43B |